Meet Manisha. Manisha is a seven-year old girl from India who was diagnosed with extra-pulmonary tuberculosis (TB) in 2008. While TB is a treatable and curable disease, in many developing countries a TB diagnosis is a death sentence since treatment is costly and time-consuming. But Manisha is a champion. After nearly seven months of treatment through a community-based program, Manisha's TB was cured in January 2009. The Lilly MDR-TB Partnership strives to improve care for the world's most vulnerable people.
With your help, stories like Manisha's will be the norm, not the exception. Join Lilly to support the fight against TB. Support one or more organizations participating in the Lilly TB Challenge. There are millions more children like Manisha that need your help today.
According to the Center for Disease Control, Tuberculosis (TB) is one of the world’s deadliest diseases:
One third of the world’s population is infected with TB.
Each year, nearly 9 million people around the world become sick with TB.
Each year, there are almost 2 million TB-related deaths worldwide.
TB is the leading killer of people who are HIV infected.
Specific MDR-TB Facts
There are approximately 440,000 new MDR-TB cases annually and 150,000 dealths.
If TB becomes drug-resistant (MDR-TB & XDR-TB), treatment can cost up to $250,000 per patient.
GlobalGiving is an online marketplace that connects you to the causes and countries you care about. You select the projects you want to support, make a tax-deductible contribution, and get regular progress updates – so you can see your impact